- Home
- VKTX vs HESM Comparison
VKTX vs HESM Comparison
Compare VKTX & HESM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- HESM
- Stock Information
- Founded
- VKTX 2012
- HESM 2014
- Country
- VKTX United States
- HESM United States
- Employees
- VKTX N/A
- HESM N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- HESM Oil & Gas Production
- Sector
- VKTX Health Care
- HESM Energy
- Exchange
- VKTX Nasdaq
- HESM Nasdaq
- Market Cap
- VKTX 4.6B
- HESM 3.8B
- IPO Year
- VKTX 2015
- HESM N/A
- Fundamental
- Price
- VKTX $42.25
- HESM $36.22
- Analyst Decision
- VKTX Strong Buy
- HESM Buy
- Analyst Count
- VKTX 12
- HESM 3
- Target Price
- VKTX $106.75
- HESM $38.67
- AVG Volume (30 Days)
- VKTX 3.7M
- HESM 752.3K
- Earning Date
- VKTX 02-05-2025
- HESM 01-29-2025
- Dividend Yield
- VKTX N/A
- HESM 7.58%
- EPS Growth
- VKTX N/A
- HESM 16.31
- EPS
- VKTX N/A
- HESM 2.37
- Revenue
- VKTX N/A
- HESM $1,456,100,000.00
- Revenue This Year
- VKTX N/A
- HESM $12.56
- Revenue Next Year
- VKTX N/A
- HESM $11.40
- P/E Ratio
- VKTX N/A
- HESM $15.28
- Revenue Growth
- VKTX N/A
- HESM 11.43
- 52 Week Low
- VKTX $17.23
- HESM $30.72
- 52 Week High
- VKTX $99.41
- HESM $39.11
- Technical
- Relative Strength Index (RSI)
- VKTX 33.93
- HESM 50.01
- Support Level
- VKTX $37.80
- HESM $35.53
- Resistance Level
- VKTX $48.55
- HESM $36.84
- Average True Range (ATR)
- VKTX 2.54
- HESM 0.86
- MACD
- VKTX -0.45
- HESM -0.13
- Stochastic Oscillator
- VKTX 30.11
- HESM 30.72
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.